Latest chemotherapy Stories
Enables physicians and patients to proactively avoid toxicities from treatments unlikely to provide benefit SAN FRANCISCO, Jan.16, 2014 /PRNewswire/ -- Castle Biosciences today announced
Ruling Appeal Establishes Calmare Treatments a "Medical Necessity" In Cancer-Related Chemotherapy Pain Case FAIRFIELD, Conn., Jan.
When a tumor is treated with an anti-cancer drug, some cells die and, unfortunately, some cells tend to live.
Blinatumomab, the first BiTE® antibody to be developed for the treatment of cancer, is being investigated by the ECOG-ACRIN Cancer Research Group in its latest trial, E1910. Philadelphia,
Known across the counter-culture industry as a widely-acclaimed odor-eliminating company, Kushley is a brand that designed its product specifically around patients who use marijuana as an alternative
DUBLIN, January 9, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/pkv9nd/liver_diseases) has announced the addition of
NEW YORK, Jan. 8, 2014 /PRNewswire/ -- Bone marrow transplants are a $1.3 billion market and the fastest-growing hospital procedure in the U.S.
- Agreement to Distribute Oncotype DX(R) in Australia and New Zealand MELBOURNE, Australia, Jan.
HAIFA, Israel, Jan.
Patients with tongue cancer who started their treatment with a course of chemotherapy fared significantly worse than patients who received surgery first.
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.